NeuroPace (NPCE) Common Equity (2020 - 2026)
NeuroPace (NPCE) recorded Common Equity of $11.88 million in Q2 2026, down 38.9% from $19.44 million a year earlier and down 17.8% from the prior quarter.
Powered by 
Analysis
NeuroPace (NPCE) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, NeuroPace reported Common Equity of $19.03 million, up 137.5% from FY2024.
- Across earlier years, Common Equity came in at $8.01 million in FY2024 (-61.2%), $20.65 million in FY2023 (-40.6%), $34.78 million in FY2022 (-52.7%) and $73.5 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Common Equity since Q4 2024.
- On a year-over-year basis, Common Equity rose in four of the last eight quarters, with growth averaging 26.4%.
- Peak year-over-year performance for Common Equity in the last five years was growth of 137.5% in Q4 2025, against a decline of 62.3% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $14.45 million (Q1 2026), $19.03 million (Q4 2025) and $18.52 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 52.69 Bn |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 51.76 Bn |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 52.59 Bn |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 18.30 Bn |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 23.99 Bn |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 25.17 Bn |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 10.72 Bn |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 24.42 Bn |
| 10 | NeuroPace | 477.90 Mn | 251.15 Mn | 18.91 Mn | 11.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.88 Mn |
| Mar 31, 2026 | 14.45 Mn |
| Dec 31, 2025 | 19.03 Mn |
| Sep 30, 2025 | 18.52 Mn |
| Jun 30, 2025 | 19.44 Mn |
| Mar 31, 2025 | 24.27 Mn |
| Dec 31, 2024 | 8.01 Mn |
| Sep 30, 2024 | 9.82 Mn |
| Jun 30, 2024 | 9.89 Mn |
| Mar 31, 2024 | 14.34 Mn |
| Dec 31, 2023 | 20.65 Mn |
| Sep 30, 2023 | 16.36 Mn |
| Jun 30, 2023 | 21.23 Mn |
| Mar 31, 2023 | 27.49 Mn |
| Dec 31, 2022 | 34.78 Mn |
| Sep 30, 2022 | 43.41 Mn |
| Jun 30, 2022 | 52.90 Mn |
| Mar 31, 2022 | 62.82 Mn |
| Dec 31, 2021 | 73.50 Mn |
| Sep 30, 2021 | 81.71 Mn |
API Access
NeuroPace Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NPCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NPCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NPCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();